korean
mer
outbreak
experienc
atyp
present
merscov
infect
three
immunocompromis
host
warrant
except
manag
case
show
delay
symptom
develop
fourday
asymptomat
period
case
experienc
incub
period
case
exhibit
persist
viral
shed
without
clinic
deterior
recogn
except
extrem
import
manag
merscovexpos
infect
patient
control
potenti
mer
outbreak
middl
east
respiratori
syndrom
viru
merscov
novel
beta
coronaviru
notori
high
fatal
comorbid
patient
exposur
viru
merscovinfect
patient
typic
present
fever
respiratori
symptom
within
incub
period
diagnosi
confirm
realtim
revers
transcriptas
polymeras
chain
reaction
rrtpcr
assay
respiratori
specimen
sever
patient
rapidli
develop
pneumonia
first
week
ill
progress
respiratori
failur
second
week
korean
mer
outbreak
experienc
atyp
present
merscov
infect
three
immunocompromis
host
suggest
except
manag
host
consid
three
patient
infect
superspread
mer
patient
emerg
depart
ed
previous
describ
clinic
cours
three
patient
concis
depict
fig
addit
case
descript
case
delay
symptom
develop
fourday
asymptomat
period
femal
known
myelodysplast
syndrom
md
visit
ed
complaint
abdomin
pain
menorrhagia
may
anemia
hemoglobin
g
dl
thrombocytopenia
platelet
count
lymphopenia
absolut
lymphocyt
count
ed
visit
discharg
ed
next
day
support
care
includ
red
blood
cell
platelet
transfus
visit
ed
symptom
june
admit
isol
room
stay
mer
patient
size
room
ed
h
may
although
mersrel
symptom
screen
merscov
infect
sputum
rrtpcr
june
result
posit
cycl
threshold
ct
valu
remain
asymptomat
statu
four
day
receiv
support
care
close
monitor
june
suddenli
develop
fever
myalgia
cough
diarrhea
chest
xray
cxr
show
pneumon
infiltr
left
upper
lobe
fig
next
day
treat
combin
antivir
regimen
ribavirin
lopinavirritonavir
interferon
alpha
followup
cxr
demonstr
aggrav
infiltr
fig
day
antivir
treatment
symptom
cxr
markedli
improv
fig
discharg
june
two
consecut
neg
test
merscov
rrtpcr
femal
receiv
autolog
peripher
blood
stem
cell
transplant
autopbsct
two
month
prior
recur
diffus
larg
bcell
lymphoma
dlbcl
visit
ed
complaint
fever
dri
cough
may
initi
laboratori
test
show
pancytopenia
white
blood
cell
count
neutrophil
lymphocyt
hemoglobin
gdl
platelet
count
empir
treat
piperacillintazobactam
febril
neutropenia
may
cxr
show
bilater
hazi
micronodular
infiltr
previous
observ
day
also
expos
mer
patient
size
room
ed
h
fever
persist
infiltr
cxr
worsen
despit
escal
antibiot
fig
suspicion
merscov
infect
sputa
repeatedli
test
merscov
rrtpcr
four
time
june
june
neg
june
admit
intens
care
unit
icu
due
sever
dyspnea
metabol
acidosi
mental
chang
fig
june
diagnos
miliari
tuberculosi
chest
comput
tomographi
ct
sputum
pcr
mycobacterium
tuberculosi
complex
antituberculosi
medic
start
meanwhil
followup
sputum
rrtpcr
merscov
equivoc
ct
valu
ct
valu
consid
posit
day
convert
posit
ct
valu
june
intub
mechan
ventil
next
day
fig
despit
worsen
cxr
oxygen
combin
antivir
treatment
ribavirin
lopinavirritonavir
interferon
alpha
could
start
june
due
pancytopenia
hepat
dysfunct
june
mycobacteri
cultur
sputum
report
growth
tuberculosi
transfer
nation
hospit
design
treatment
infecti
diseas
juli
expir
juli
male
receiv
autopbsct
six
month
prior
due
peripher
cell
lymphoma
ptcl
visit
ed
complaint
cough
sputum
mild
fever
may
share
radiolog
room
time
period
min
h
mer
patient
next
day
chest
ct
reveal
mild
infiltr
lower
lobe
appar
cxr
diagnosi
communityacquir
pneumonia
discharg
oral
antibiot
two
day
intraven
antibiot
treatment
howev
fever
persist
lymphomarel
fever
suspect
june
admit
gener
ward
evalu
statu
lymphoma
includ
petct
bone
marrow
examin
reveal
recurr
ptcl
suppress
lymphoma
activ
mgday
methylprednisolon
administ
three
day
fever
subsid
steroid
stop
fever
cough
sputum
aggrav
cxr
show
newli
develop
infiltr
upper
lobe
fig
base
contact
histori
mer
patient
ed
test
merscov
rrtpcr
june
posit
ct
valu
june
mgday
oral
prednison
readminist
one
week
control
autoimmun
hemolyt
anemia
taper
mgday
averag
thereaft
combin
antivir
agent
ribavirin
lopinavirritonavir
interferon
alpha
start
june
maintain
day
although
experienc
symptom
aggrav
initi
two
week
follow
relief
pneumon
infiltr
cxr
sustain
fig
c
viral
shed
continu
high
viral
load
one
month
transfer
nation
hospit
design
treatment
infecti
diseas
juli
although
mani
clinic
studi
merscov
infect
report
date
well
understood
whether
viral
shed
merscov
preced
symptom
onset
likewis
likelihood
progress
asymptomat
rrtpcrposit
case
symptomat
ill
also
unclear
korean
outbreak
patient
diagnos
merscov
infect
presenc
symptom
asymptomat
rrtpcrposit
person
progress
symptomat
ill
howev
case
underli
md
progress
mer
pneumonia
fourday
asymptomat
period
wherea
merscov
infect
gener
show
stepwis
progress
ie
exposur
symptom
develop
viral
shed
pneumonia
develop
respiratori
failur
case
show
pneumon
infiltr
cxr
togeth
symptom
develop
simultan
develop
symptom
pneumonia
suggest
symptom
express
might
delay
mask
rather
shown
lag
overal
diseas
progress
case
impli
mersexpos
immunocompromis
host
properli
isol
close
monitor
even
initi
complain
symptom
incub
period
merscov
known
within
day
exposur
contact
investig
monitor
typic
perform
base
standard
howev
case
show
longer
incub
period
day
probabl
owe
suppress
immun
statu
due
multipl
cours
chemotherapi
autopbsct
case
suggest
incub
period
immunocompromis
host
could
longer
day
although
patient
experienc
persist
fever
progress
consolid
cxr
due
exist
tuberculosi
sputum
rrtpcr
merscov
consecut
neg
post
exposur
day
dpex
moreov
first
nonneg
rrtpcr
dpex
show
equivoc
result
followup
test
reveal
increas
viral
load
progress
impli
viral
shed
start
around
dpex
indic
incub
period
day
even
though
possibl
fals
neg
earlier
test
due
inadequ
specimen
exclud
recogn
potenti
except
long
incub
period
immunocompromis
host
extrem
import
epidemiolog
investig
infect
control
real
world
patient
monitor
least
three
week
exposur
mer
contact
trace
base
exposur
within
three
week
base
experi
sever
acut
respiratori
infect
includ
sever
acut
respiratori
syndrom
coronaviru
sarscov
highdos
corticosteroid
recommend
avoid
manag
merscov
infect
case
use
prolong
corticosteroid
therapi
control
lymphoma
activ
hemolyt
anemia
probabl
contribut
persist
viral
shed
without
clinic
progress
diseas
inevit
use
corticosteroid
hamper
recoveri
patient
also
control
transmiss
viral
shed
persist
ct
valu
far
mean
valu
spreader
korean
mer
outbreak
high
viral
load
risk
factor
transmiss
appropri
airborn
infect
isol
room
care
wear
remov
ppe
requir
manag
patient
consid
aspect
patient
avoid
corticosteroid
therapi
aggress
manag
symptom
onset
includ
experiment
therapeut
measur
antivir
therapi
convalesc
plasma
infus
therapi
likewis
use
immunosuppress
agent
also
cautiou
aggress
manag
patient
consid
use
unavoid
present
atyp
present
merscov
infect
three
immunocompromis
host
recogn
except
extrem
import
manag
merscovexpos
infect
patient
control
potenti
mer
outbreak
futur
none
